← All briefs
FIELD NOTE

The Hospital CISO's Problem: Proving Your Defenses Actually Stop an Attack

The Hospital CISO's Problem: Proving Your Defenses Actually Stop an Attack

If you run security for a hospital or health system, you already know the hardest question in the building isn't asked by an attacker. It's asked by your board, your OCR examiner, and your cyber insurer: “Can you prove our defenses actually work?” Compliance frameworks tell you which controls you have deployed. They do not tell you whether those controls would stop a real intrusion before it reaches the EHR, the imaging archive, or the infusion pumps on the floor. For a CISO whose failure mode is measured in disrupted patient care, that gap between compliant and secure is the whole job.

The stakes are not abstract. Healthcare carried the highest average breach cost of any vertical in 2025 at roughly $7.42M per incident, and it remains one of the most ransomware-targeted sectors in the economy. When an attack lands, it doesn't just leak records — it diverts ambulances, delays procedures, and forces clinicians back to paper. The pressure to be more secure runs headlong into the one thing a hospital cannot tolerate: downtime that touches patient care.

Why hospitals are uniquely hard to defend

Five dynamics make the hospital environment harder to secure than almost any other, and every one of them widens the space between what your compliance report says and what an attacker can actually do:

  • Relentless ransomware pressure: Attackers deliberately target clinical systems and backup infrastructure, knowing hospitals are more likely to pay to restore care.
  • An exploding IoMT attack surface: Connected medical devices are often legacy, difficult or impossible to patch, and poorly segmented from the rest of the network.
  • Rapid AI adoption: AI in diagnostics, administration, and operations introduces new and poorly understood exposure vectors faster than most programs can assess them.
  • Regulatory scrutiny: HIPAA, active OCR enforcement, and evolving FDA device expectations all demand demonstrable evidence, not just documented intent.
  • Chronic resource constraints: Most security teams are asked to continuously defend a sprawling hybrid environment with a fraction of the staff the risk warrants.

How an attacker actually moves through your network

Modern healthcare intrusions tend to follow a predictable arc. Initial access usually comes through compromised remote access (VPN or RDP), phishing, or a third-party and supply-chain compromise. From there, attackers lean heavily on valid accounts — stolen or misused credentials — to move laterally toward the assets that matter: EHR systems, PACS imaging, medical devices, and the backup infrastructure you'd rely on to recover. The final stage is impact: ransomware deployment, deliberate destruction of backups, data exfiltration, and clinical disruption. Increasingly, AI is being folded into the early stages to make phishing and reconnaissance more convincing.

The uncomfortable truth is that most of these paths run straight through controls that passed their last audit. The question is never whether you have a firewall, segmentation policy, or EDR agent. It's whether that specific chain of steps — this exposed remote-access point, into these credentials, across to that unpatched device — would be stopped in your environment, today.

What “proof of effectiveness” means to each stakeholder

Part of what makes the CISO role so demanding in healthcare is that “proof” means something different to every party you answer to. Effective evidence has to translate across all of them:

  • OCR: Wants to see that you conducted reasonable risk analyses and implemented appropriate safeguards, with regular testing and remediation.
  • Boards & risk committees: Want findings connected to a reduced likelihood and impact of a future incident — in business terms, not packet captures.
  • Cyber insurers: Increasingly require proof of regular testing, validated backups, and real segmentation before they write or renew a policy.
  • FDA (for device makers and IoMT): Expects demonstrated identification and mitigation of cybersecurity risk across the device lifecycle.
  • State AGs & plaintiffs: Look for evidence that the organization implemented reasonable security and acted on known risks.

What continuous, non-disruptive validation gives the hospital CISO

A once-a-year penetration test is a snapshot of an environment that changes daily. In a hospital, that snapshot is out of date before the report is delivered. What the role actually calls for is continuous adversarial validation: safely and repeatedly proving whether real attack paths to your critical systems would succeed — without ever touching production or interrupting care.

When you evaluate a validation approach for a hospital environment, a few criteria separate genuine assurance from theater. It should run continuously rather than annually. It should test inside simulated or mirrored environments so nothing ever touches live clinical systems — no downtime, no patient-safety risk. It should produce findings in two registers at once: the technical detail your operators need to remediate, and the attack-path visualization and executive summary your board, OCR, and insurers will actually read. And for medical-device and IoMT fleets specifically, it must be able to safely test attack paths without risking a device in service. This is the standard SIEGE was built to meet — its reinforcement-learning agents were developed under the DARPA CASTLE program and proven across U.S. Government and DoD networks — but the criteria hold no matter whose platform you assess.

Where to start

You don't have to boil the ocean. For most hospital security programs, the highest-value first moves are the same:

  • Continuously map exposed remote access and the lateral paths that lead from it to EHR, PACS, and clinical systems.
  • Validate the segmentation between your IT network and your medical-device environment — assume it's weaker than the policy says.
  • Prove your backups are both intact and actually isolated from the paths ransomware would take to reach them.
  • Frame every finding in the language of patient-care impact and regulatory exposure, so the risk is legible to clinicians and executives alike.

Compliance tells you what you have. Continuous adversarial validation tells you what actually works — with dated, auditable evidence you can hand to your board, your regulator, and your insurer. In an environment where an outage is measured in delayed care, that difference is the one worth investing in.

See SIEGE run against an environment like yours.

Book a working session or take the free Exposure Gap Assessment.

Explore the Platform